Seller record · Telehealth service

Levers Health

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 2 of 8 criteria. S2, prescription gating: Payment details come before any medical question. The cart lists checkout first and states that the medical intake form is sent by text and email after checkout, with no charge unless a doctor approves. 1 more criterion also fails; see the table below.

At a glance

Levers HealthTelehealth service

6/8criteria passed

Price: Semaglutide $247 a month on subscription, tirzepatide from $296
Sells: compounded semaglutide, compounded tirzepatide, and 6 more
FDA letters: None on file

Visit Levers Health See all eight dispositions

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

A telehealth service selling compounded semaglutide and tirzepatide, including low-dose plans, beside sermorelin, NAD+, glutathione and GHK-Cu cream. Its cart takes checkout before the medical intake form, and it names Strive Compounding Pharmacy as its pharmacy.

Operating entity Levers Health LLC

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	Levers Health's website; Levers Health's about us page
S2	Prescription gating	FAIL	Levers Health's cart; Levers Health's FAQ
S3	Pharmacy identification	PASS	Levers Health's privacy policy
S4	Compounding disclosure	PASS	Levers Health's semaglutide program product page; Levers Health's tirzepatide product page
S5	Analytical documentation	FAIL	Levers Health's NAD+ injection product page; Levers Health's sermorelin product page
S6	Business address	PASS	Levers Health's contact page; Levers Health's terms and conditions; Levers Health's privacy policy
S7	Price disclosure	PASS	Levers Health's semaglutide program product page; Levers Health's semaglutide product page; Levers Health's tirzepatide product page; Levers Health's sermorelin product page; Levers Health's NAD+ injection product page
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSA licensed physician in the patient's state reviews and prescribes every plan, and the about page names a board-certified medical director.Source: Levers Health's website; Levers Health's about us page.

S2FAILPayment details come before any medical question. The cart lists checkout first and states that the medical intake form is sent by text and email after checkout, with no charge unless a doctor approves.Source: Levers Health's cart; Levers Health's FAQ.

S3PASSStrive Compounding Pharmacy is named as the nationwide pharmacy partner, with addresses in Gilbert, Arizona and Tampa, Florida, in the privacy policy.Source: Levers Health's privacy policy.

S4PASSEach GLP-1 product page states that compounded medications are not reviewed or approved by the FDA, and the footer repeats it on every page.Source: Levers Health's semaglutide program product page; Levers Health's tirzepatide product page.

S5FAILNo certificate of analysis or lot document is published. The NAD+ and sermorelin pages say only 3rd-party tested.Source: Levers Health's NAD+ injection product page; Levers Health's sermorelin product page.

S6PASSLevers Health LLC at 7067 East Dale Lane, Scottsdale, AZ 85266, printed on the contact page, in the terms and in the privacy policy.Source: Levers Health's contact page; Levers Health's terms and conditions; Levers Health's privacy policy.

S7PASSCompounded semaglutide at $247 a month on subscription or $390 for a single bottle, and compounded tirzepatide from $296 a month or $490 for a single 20mg bottle. Sermorelin at $222 a month on a one-month plan or $297 bought once, and the NAD+ injection at $197 a month or $247 bought once.Source: Levers Health's semaglutide program product page; Levers Health's semaglutide product page; Levers Health's tirzepatide product page; Levers Health's sermorelin product page; Levers Health's NAD+ injection product page.

S8PASSNo FDA warning letter names Levers Health or the operating entity Levers Health LLC, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, low-dose and microdose semaglutide and tirzepatide, sermorelin, NAD+ injection, glutathione, GHK-Cu cream, lipotropic MIC and B12 injection.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide Who sells sermorelin Who sells NAD+Who sells glutathione Who sells GHK-Cu

Unpaid link. Levers Health does not pay the site, and nothing is earned when it is used. Funding.

Visit Levers Health

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.